Utility of Pharmacological Agents for Diabetes Mellitus in the Prevention of Alzheimer’s Disease: Comparison of Metformin, Glucagon-Like Peptide-1 (GLP-1) Agonists, Insulin, and Sulfonylureas. Here, GLP1R is linked to diabetes mellitus.